Bank of America
HRTX icon

Bank of America’s Heron Therapeutics HRTX Stock Holding History

Bank of America’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-16,800
Closed -$436K – 7231
2018
Q4 		$436K Hold
16,800
– – ﹤0.01% 5030
2018
Q3 		$532K Sell
16,800
-114,300
-87% -$4.26M ﹤0.01% 4908
2018
Q2 		$5.09M Buy
+131,100
New +$4.17M ﹤0.01% 3138
2018
Q1 		– Sell
-14,500
Closed -$262K – 7197
2017
Q4 		$262K Buy
+14,500
New +$236K ﹤0.01% 5285
2016
Q2 		– Sell
-43,700
Closed -$830K – 7213
2016
Q1 		$830K Buy
+43,700
New +$862K ﹤0.01% 4234

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Bank of America's HRTX Position: Q1 2026 in Review

Bank of America increased its Heron Therapeutics (HRTX) stake by 20% in Q1 2026, buying an estimated $30.7K and bringing the position to 160,979 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #5481.

Bank of America first reported a position in HRTX in Q2 2014 and has held it in 48 quarters since. The position peaked at $11M in Q1 2019. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • Bank of America held 160,979 shares of Heron Therapeutics worth $129K as of Q1 2026.
  • Bank of America bought 26,534 Heron Therapeutics shares in Q1 2026, an estimated $30.7K.
  • Heron Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5481 holding.
  • Bank of America first reported a position in Heron Therapeutics in Q2 2014 and has held it in 48 quarters since.
  • Bank of America's Heron Therapeutics position peaked at $11M in Q1 2019.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.